Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Peptides & Research Compounds
1
Posts
1
Users
0
Reactions
319
Views
Topic starter
03/10/2022 5:42 pm
Bloodwork question about semaglutide. Baseline, a year in, and the numbers moved in a direction I did not expect.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Muscle loss is the thing to watch, which means protein and resistance training rather than appetite alone.
Interested in the methods more than the conclusion.